HIF1A and nasopharyngeal carcinoma: Further ChIP assays using anti-HIF1α antibody showed direct binding of HIF1α to the promoter of miR-519d in NPC cells, which can be further enhanced by 24 h of 100 μM CoCl2 treatment (Fig. 5b).